We are live on ! Find out more
ROIV icon

Roivant Sciences

78 hedge funds and large institutions have $1.19B invested in Roivant Sciences in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more call options, than puts

Call options by funds: $566K | Put options by funds: $222K

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

10% more funds holding

Funds holding: 7178 (+7)

1.23% more ownership

Funds ownership: 51.44%52.67% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

19% less capital invested

Capital invested by funds: $1.47B → $1.19B (-$274M)

Holders
78
Holders Change
+7
Holders Change %
+9.86%
% of All Funds
1.34%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
15
Increased
27
Reduced
17
Closed
7
Calls
$566K
Puts
$222K
Net Calls
+$344K
Net Calls Change
+$442K

ROIV Hedge Fund Activity: Q3 2022 in Review

78 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q3 2022, worth a combined $1.19B — down 19% from $1.47B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ROIV positions and 7 closed out — a net gain of 8 holders — while 27 added to existing stakes and 17 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $10.5M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $3.57M sold.

  • 78 institutional investors held Roivant Sciences (ROIV) as of Q3 2022, up from 71 in Q2 2022.
  • Funds reported $1.19B of Roivant Sciences stock for Q3 2022, down 19% quarter-over-quarter.
  • 15 funds opened new Roivant Sciences positions in Q3 2022 and 7 closed out, a net change of +8 holders.
  • The largest Roivant Sciences buyer in Q3 2022 was Adage Capital Partners, an estimated $10.5M added.
  • The largest Roivant Sciences seller in Q3 2022 was Point72 Asset Management, an estimated $3.57M sold.

Based on aggregated 13F filings for Q3 2022.